drugset / Trial / NCT00930618

Reduction of Cesareans by Nitric Oxide (NO) Donors in Post Term Pregnancies

NCT00930618 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to determine whether cervical ripening with isosorbide mononitrate reduce caesarean section in women with post term pregnancies.

Timeline

Start
2009-06
Primary completion
2013-12
Completion
2014-04

Outcome

Missed primary endpoint

paper Outpatient cervical ripening with vaginal isosorbide mononitrate for prolonged pregnancy in nulliparous women does not reduce cesarean delivery rate. PMID 25415159 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Isosorbide Mononitrate Other / unclassified 40 mg Other

Indications

No indication recorded.